What Is Mounjaro 7.5 mg?
Mounjaro (tirzepatide) is a once-weekly injectable for type 2 diabetes that also supports weight management. The 7.5 mg dose is a mid-range maintenance level after stepping up from lower doses.
How to Take Mounjaro 7.5 mg
Weekly Injection: Administer 7.5 mg subcutaneously (abdomen, thigh, or upper arm) on the same weekday each week.
Rotate Sites: Change injection site each week to prevent skin irritation.
Missed Dose: If under 5 days late, inject as soon as you remember; if over 5 days, skip and resume next scheduled dose.
Key Benefits for Beginners
Improved Blood Sugar Control: Boosts insulin when needed and lowers excess glucagon.
Appetite Suppression: Slows gastric emptying so you feel fuller on smaller meals.
Enhanced Weight Loss: Many users see steady, healthy reductions in body weight.
Common Side Effects
Nausea or Vomiting: Usually eases after a few weeks; try smaller, bland meals.
Diarrhea or Constipation: Drink plenty of water and add fiber gradually.
Abdominal Discomfort: Warm compresses can help; ask your doctor about antacids.
Injection-Site Reactions: Rotate sites and apply gentle pressure or a cold pack if needed.
Alert: Seek medical help for severe abdominal pain, persistent vomiting, or signs of pancreatitis (sharp upper-abdominal pain radiating to your back).
